Invited Plenary LecturersSimeon Arseniyadis (simeon.arseniyadis@icsn.cnrs-gif.fr), Institut de chemie des substances naturelles, Centre national de la reserche scientifique, Gif sur Yvette, France Mark C. Bagley (BagleyMC@cardiff.ac.uk), School of Chemistry, Cardiff University, Cardiff, Wales, UK Maurice C.R. Franssen (Maurice.Franssen@wur.nl), Laboratory of Organic Chemistry, Wageningen University, The Netherlands Michal Hocek (hocek@uochb.cas.cz), Institute of Organic Chemistry and Biochemistry, Academy of Sciences, Prague, Czech Republic Viktor Krchnak (vkrchnak@nd.edu), Department of Chemistry and Biochemistry, University of Notre Dame, USA Peter Langer (peter.langer@uni-rostock.de), Institut für Chemie, Universität Rostock, Rostock, Germany Lechoslaw Latos-Grazynski (llg@wchuwr.pl), Department of Chemistry, University of Wroclaw, Poland Romano VA Orru (orru@few.vu.nl), Synthetic & Bioorganic Chemistry, Faculty of Sciences,VU University, Amsterdam, The Netherlands Kamil Paruch (paruch@chemi.muni.cz), Department of Chemistry Masaryk University, Brno, Czech Republic
"Discovery and preclinical profiling of new John Pavey (john.pavey@astrazeneca.com), AstraZeneca "AZD7009-complicated heterocycle, significant improvements and innovation to deliver a process capable of high volume manufacture" Jakub Švenda (jakub@svenda.com), Harvard University, USA/Max Planck Institute, Dortmund, Germany "A multiply convergent synthetic route to trioxacarcins" |